Zimmer Biomet

Forecast & Rating27 analysts currently cover Zimmer Biomet, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $107.57, about 9.8% upside from the current price of $97.97. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 35.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Zimmer Biomet's outlook. Data as of Aug 13, 2026; for reference only and not investment advice.